Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Change in Taxes (2016 - 2025)

Haemonetics has reported Change in Taxes over the past 17 years, most recently at $1.8 million for Q4 2025.

  • Quarterly results put Change in Taxes at $1.8 million for Q4 2025, up 265.95% from a year ago — trailing twelve months through Dec 2025 was -$4.2 million (down 178.79% YoY), and the annual figure for FY2025 was -$226000.0, down 122.99%.
  • Change in Taxes for Q4 2025 was $1.8 million at Haemonetics, up from $210000.0 in the prior quarter.
  • Over the last five years, Change in Taxes for HAE hit a ceiling of $6.9 million in Q3 2024 and a floor of -$3.3 million in Q2 2025.
  • Median Change in Taxes over the past 5 years was -$191500.0 (2021), compared with a mean of -$7500.0.
  • Peak annual rise in Change in Taxes hit 9362.96% in 2023, while the deepest fall reached 1606.29% in 2023.
  • Haemonetics' Change in Taxes stood at -$356000.0 in 2021, then surged by 149.16% to $175000.0 in 2022, then plummeted by 1606.29% to -$2.6 million in 2023, then soared by 59.22% to -$1.1 million in 2024, then soared by 265.95% to $1.8 million in 2025.
  • The last three reported values for Change in Taxes were $1.8 million (Q4 2025), $210000.0 (Q3 2025), and -$3.3 million (Q2 2025) per Business Quant data.